The Allevi Liver dECM promises the fabrication of liver tissue that has a more representative physiological function. The product uses a combination of a type I collagen Allevi bioink for patterning as well as Xylyx Bio’s highly desired liver-specific TissueSpec® ECM to enhance specialized biological response.
Xylyx Bio products for cell culture are obtained from porcine or human tissue sources and processed to various formats, enabling cell culture models that are significantly more predictive of physiology. Their 3D TissueSpec® ECM hydrogels and scaffolds provide support to cell culture models, facilitating the acceleration of drug discovery, development and tissue regeneration.
“We are thrilled to partner with Allevi and share our expertise in tissue-specific ECM,” stated Andrea Nye, Chief Executive Officer at Xylyx Bio. “Recognizing the importance of the native cellular microenvironment, Xylyx Bio harnesses the body’s innate biology in the form of tissue-specific extracellular matrix. By sourcing extracellular matrix from native organs and tissues, Xylyx produces tissue-specific substrates that comprise both the mechanical properties and complex ratios of ECM components specific and unique to each tissue and organ type.”
Founded in 2014, Allevi claims that its “mission is to provide users the ability to design, engineer, and manufacture 3D tissue.” To deliver important building blocks and provide users with the best experience possible to drive new scientific discoveries, Allevi is hopeful that the new dECM bioink will provide scientists a revolutionary approach that allows scientists to print 3D tissue structures with biochemical and mechanical features inherent in human physiology.
[Images: Allevi and Xylyx Bio]
Xylyx Bio’s Co-founder and Chief Strategy Officer, John O’Neil, added that a “deeper understanding of the comprehensive nature of tissues and cells and their interaction with the cellular microenvironment – that is, the extracellular matrix – holds great promise to lead to a paradigm shift in 3D bioprinting, allowing researchers to study physiologic activity of cells in vitro towards a better understanding of disease and development of more effective drugs and treatments.”
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
You May Also Like
3D Printing News Briefs, February 17, 2024: Shot Blasting, Service Bureaus, & More
In today’s 3D Printing News Briefs, we’re starting out with post-processing, as SKZ Würzburg is using a shot blast system from AM Solutions for its research. Moving on to business,...
MIT Researchers Use AI to Optimize Stiffness and Toughness Balance in 3D Printed Parts
In January, researchers from the Massachusetts Institute of Technology’s (MIT’s) Computer Science and Artificial Intelligence Laboratory (CSAIL) published a study in the journal Science Advances, which details an algorithm they...
Northrop Grumman Taps GKN Aerospace for 3D Printed Solid Rocket Motors
At the beginning of January, UK aerospace manufacturer GKN Aerospace announced it was investing over $60 million to boost its additive manufacturing (AM) capacity in Trollhättan, Sweden. Now, GKN is...
3D Printing News Unpeeled: 3D Printed Golf Clubs, an India Made SLS Printer, MIT Liquid Metal and a Vietnamese Trauma Implant
After Cobra’s King putters, the firm now has a line of 8 clubs that use MJF binder jet. The Agera and others have different sized insets and cost $349. The...
Upload your 3D Models and get them printed quickly and efficiently.